The seventh triMS.online conference

BTK inhibitors: an exciting new era in MS therapy

Took place on Thursday 25 May 2023

triMS.online  would like to acknowledge that this event is supported by an Independent Medical Educational Grant from Sanofi and sponsorship provided by Novartis.

About this event

The seventh triMS.online meeting took place on Thursday 25 May 2023 on the theme BTK inhibitors: an exciting new era in MS therapy.

This triMS.online conference discussed the following topics and featured the latest data and clinical insights on the topic.

BTK inhibition as a potential therapeutic target in MS
The prospects for long term administration in MS
Clinical development of BTK inhibitors in MS
Learnings from a safety perspective
Positioning in the treatment pathway

triMS.online events offer an interactive event experience:

Short 10-minute presentations and TED-style talks
Posters
Meet the Expert sessions
Access to exhibit booths
Access to content live and after the event

We are committed to creating an environment in which healthcare professionals and researchers in the field of MS can discuss the latest information and network with fellow professionals free of charge and from the comfort of their home or workplace, without the need to travel.

Scientific programme

13:30	Exhibit Hall Congress and exhibit hall open Free time to explore the exhibition stands and poster hall
14:00	Welcome Jiwon Oh, Canada (Chair)
14:10	Sanofi Meet the expert session The role of microglia in MS and other neurodegenerative diseases Heinz Wiendl, Germany
14:30	Q&A Heinz Wiendl, Germany Jiwon Oh, Canada
14:40	What is BTK inhibition? Jacqueline Nicholas, USA
14:50	BTK inhibition - a potential therapeutic target in MS Martin Weber, Germany
15:00	Q&A Jacqueline Nicholas, USA Martin Weber, Germany Jiwon Oh, Canada
15:10	Sanofi Meet the expert session Subtle MS disease worsening and its underlying biology Benjamin Greenberg, USA
15:30	Q&A Benjamin Greenberg, USA Jiwon Oh, Canada
15:40	Break
16:00	Prospects of BTK inhibitors for long-term administration in MS Kottil Rammohan, USA Not available on demand
16:15	Q&A Kottil Rammohan, USA Jiwon Oh, Canada
16:20	Clinical development of BTK inhibitors in MS - what do we know so far Karolina Piasecka-Stryczynska, Poland
16:35	Learnings from other autoimmune diseases - a safety perspective Mohammad Sahraian, Iran
16:50	Q&A Karolina Piasecka-Stryczynska, Poland Mohammad Sahraian, Iran Jiwon Oh, Canada
17:00	Positioning of BTK inhibitors in the MS treatment landscape Frauke Zipp, Germany
17:15	Q&A Frauke Zipp, Germany Jiwon Oh, Canada
17:25	Close Jiwon Oh, Canada (chair)

Our supporters

triMS.online  would like to acknowledge that this event is supported by an Independent Medical Educational Grant from Sanofi and a sponsorship provided by Novartis

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_D3ZC0HSF33	2 years	This cookie is installed by Google Analytics.
_gat_gtag_UA_45336067_7	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
vuid	2 years	Vimeo installs this cookie to collect tracking information by setting a unique ID to embed videos to the website.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Cookie	Duration	Description
__cf_bm	30 minutes	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.

About this event

Scientific programme

Exhibit Hall

Congress and exhibit hall open

Welcome

Sanofi Meet the expert session

The role of microglia in MS and other neurodegenerative diseases

Q&A

What is BTK inhibition?

BTK inhibition - a potential therapeutic target in MS

Q&A

Sanofi Meet the expert session

Subtle MS disease worsening and its underlying biology

Q&A

Break

Prospects of BTK inhibitors for long-term administration in MS

Not available on demand

Q&A

Clinical development of BTK inhibitors in MS - what do we know so far

Learnings from other autoimmune diseases - a safety perspective

Q&A

Positioning of BTK inhibitors in the MS treatment landscape

Q&A

Close

Our supporters